Year 2013,
Volume: 3 Issue: 5, 0 - 0, 01.05.2013
Abstract
In this article, not only the importance of treatment of bipolar episodes but also aiming to prevent the relapses is discussed. Thus, it emphasises the prevention of exacerbation of disorder in time and permanent cognitive defects. In the latter part, the principles of pharmacologic treatment is adressed.
References
- Tohen M, Waternaux CM, Tsaung MT. Outcome in mania. Arch Gen Psychiatry. 1990:47;1106-11.
- Işık E (2012) İki uçlu bozukluğun tedavisi. Çocuk, ergen, erişkin ve yaşlılıkta depresif ve İki uçlu bozukluklar. Işık E (editör). Işık U, Işık Taner Y (yrd. Editörler) Basımda.
- Judd LL, Akiskal HS, Schettler PJ ve ark. Prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry. 2003:60;261-9.
- Goldberg JF (2002) APA 155 Treating Bipolar Disorder. Annual Meeting, Philadelphia.
- Grunze H, Vieta E, Goodwin GM ve ark. WFSBP Task Force On Treatment Guidelines For Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 2010:11;81-109.
- Sachs GS. (2002) Advances in the treatment of mania. New devolopment in the treatment of bipolar disorder. APA 155th annual meeting, 19, Philadelphia.
- Hirshfield R, Clayton PJ, Cohen ve ark. (2000) Practice Guideline for the treatment of patient with bipolar disorder. American Psychiatric Association Practice Guidlines for the treatment of psychiatric disorders. Compendium Washington DC:497-563.
- Vieta E, Gasto C, Colom F ve ark. Role of Risperidon in bipolar II: An open 6-month study. Journal Affect Disord 2001:67;213-9
- Chwieduk CM, Scott LJ Asenapine: a review of its use in the management of mania in adults with bipolar I disorder. CNS Drugs. 2011:1;25:251-67. Scott J. Cognitive therapy as an adjunct to medication in bipolar disorder. Br J Psychiatry, Suppl. 2001:41;164-8.
- DeLeon OA. Antiepileptic drugs for the acute and maintenance treatment of bipolar disorder. Harv Rev Psychiatry.2001:9:209-12.
- Shi L, Juarez R, Hackworth J ve ark. Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes. Current Medical Research and Opinion. 2006:22;961-6.
- Alvarez G, Marsh W, Camacho IA ve ark. Effeetiveness and tolerability of carbamazepine vs. oxcarbazepine as mood stabilizers. Clin Res Reg Alfairs. 2003:20;365-72.
İki uçlu bozuklukta psikofarmakolojik tedavinin gerekçeleri, genel tedavi ilkeleri ve uygulama biçimleri
Abstract
Bu makalede iki uçlu bozukluğun tedavisinde sadece atakların değil, nükslerin de önlenmesinin, amaçlanmasının önemine işaret edilmektedir. Böylece hastalığın gitgide şiddetlenmesinin ve de kalıcı bilişsel bozuklukların ortaya çıkışının engellenebileceği vurgulanmaktadır. Daha sonraki bölümde ise psikofarmakolojik tedavinin ilkeleri ele alınmaktadır.
References
- Tohen M, Waternaux CM, Tsaung MT. Outcome in mania. Arch Gen Psychiatry. 1990:47;1106-11.
- Işık E (2012) İki uçlu bozukluğun tedavisi. Çocuk, ergen, erişkin ve yaşlılıkta depresif ve İki uçlu bozukluklar. Işık E (editör). Işık U, Işık Taner Y (yrd. Editörler) Basımda.
- Judd LL, Akiskal HS, Schettler PJ ve ark. Prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry. 2003:60;261-9.
- Goldberg JF (2002) APA 155 Treating Bipolar Disorder. Annual Meeting, Philadelphia.
- Grunze H, Vieta E, Goodwin GM ve ark. WFSBP Task Force On Treatment Guidelines For Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 2010:11;81-109.
- Sachs GS. (2002) Advances in the treatment of mania. New devolopment in the treatment of bipolar disorder. APA 155th annual meeting, 19, Philadelphia.
- Hirshfield R, Clayton PJ, Cohen ve ark. (2000) Practice Guideline for the treatment of patient with bipolar disorder. American Psychiatric Association Practice Guidlines for the treatment of psychiatric disorders. Compendium Washington DC:497-563.
- Vieta E, Gasto C, Colom F ve ark. Role of Risperidon in bipolar II: An open 6-month study. Journal Affect Disord 2001:67;213-9
- Chwieduk CM, Scott LJ Asenapine: a review of its use in the management of mania in adults with bipolar I disorder. CNS Drugs. 2011:1;25:251-67. Scott J. Cognitive therapy as an adjunct to medication in bipolar disorder. Br J Psychiatry, Suppl. 2001:41;164-8.
- DeLeon OA. Antiepileptic drugs for the acute and maintenance treatment of bipolar disorder. Harv Rev Psychiatry.2001:9:209-12.
- Shi L, Juarez R, Hackworth J ve ark. Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes. Current Medical Research and Opinion. 2006:22;961-6.
- Alvarez G, Marsh W, Camacho IA ve ark. Effeetiveness and tolerability of carbamazepine vs. oxcarbazepine as mood stabilizers. Clin Res Reg Alfairs. 2003:20;365-72.
There are 12 citations in total.
Details
| Primary Language | Turkish |
|---|---|
| Journal Section | Articles |
| Authors | |
| Publication Date | May 1, 2013 |
| Published in Issue | Year 2013 Volume: 3 Issue: 5 |